Recent progress in sepsis epidemiology - Have we learned enough?

Critical Care

Volumn 7, Issue 5, 2003, Pages 333-334

  Gerlach, Herwig ^a   Keh, Didier ^b  

^a VIVANTES KLINIKUM NEUKÖLLN   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE DISEASE; ARTICLE; ARTIFICIAL VENTILATION; CARDIOVASCULAR DISEASE; GENETIC ANALYSIS; HEALTH CARE QUALITY; HEMODYNAMICS; HOSPITAL INFECTION; HUMAN; IMMUNE RESPONSE; INTENSIVE CARE; INTENSIVE CARE UNIT; MEDICAL RESEARCH; MORTALITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SEPSIS; SEPTIC SHOCK; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

ADULT; AGED; DEVELOPED COUNTRIES; FEMALE; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; SEPSIS;

EID: 0141989549     PISSN: 13648535     EISSN: None     Source Type: Journal    
DOI: 10.1186/cc2175     Document Type: Article

References (13)

1. Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, Fisher CJ Jr; Recombinant human protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study group: Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001, 344:699-709.
2. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M; Early Goal-Directed Therapy Collaborative Group: Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001, 345: 1368-1377.
3. Annane D, Sébille V, Charpentier C, Bollaert PE, François B, Korach JM, Capellier G, Cohen Y, Azoulay E, Troché G, Chaumet-Riffaut P, Bellissant E: Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002, 288:862-871.
4. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR: Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001, 29:1303-1310.
5. Alberti C, Brun-Buisson C, Burchardi H, Martin C, Goodman S, Artigas A, Sicignano A, Palazzo M, Moreno R, Boulme R, Lepage E, Le Gall R: Epidemiology of sepsis and infection in ICU patients from an international multicenter cohort study. Intensive Care Med 2002, 28:108-121.
6. Vincent JL, Sakr Y, Carlet J, Gerlach H, Le Gall JR, Moreno R, Payen D, Ranieri M, Reinhart K, Charles Sprung, on behalf of the SOAP investigators: Sepsis Occurrence in Acutely ill Patients (SOAP): results of a large European multicentric study [abstract]. Abstract presented at the 32nd Critical Care Congress of the Society of Critical Care Medicine, 2003, San Antonio, USA.
7. The Acute Respiratory Distress Syndrome Network: Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000, 342:1301-1308.
8. Angus DC, Wax RS: Epidemiology of sepsis: an update. Crit Care Med 2001, 29(suppl):S109-S116.
9. Cheon-Lee E, Amstey MS: Compliance with the Centers for Disease Control and prevention antenatal culture protocol for preventing group B streptococcal neonatal sepsis. Am J Obstet Gynecol 1998, 179:77-79.
10. Hotchkiss RS, Karl IE: The pathophysiology and treatment of sepsis. N Engl J Med 2003, 348:138-150.
11. Sessler CN, Shephard W: New concepts in sepsis. Curr Opin Crit Care 2002, 8:465-472.
12. Brun-Buisson C: The epidemiology of the systemic inflammatory response. Intensive Care Med 2000, 26(suppl 1):S64-S74.
13. Coughlin MT, Angus DC: Economic evaluation of new therapies in critical illness. Crit Care 2003, 31 (suppl):S7-S16.